Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:10 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
NCT00231192 · Children's Hospital of Philadelphia · NA · withdrawn · last registry update 2015-03-12 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Unable to recruit any subjects” | – | Registry record, Children's Hospital of Philadelphia |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against KCNJ11 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2015-10-29Results posted on the registry: Merck Sharp & Dohme LLC, Omarigliptin + Matching placebo to omarigliptin (NCT01697592)
- 2015-08-20Results posted on the registry: Bial - Portela C S.A., BIA 9-1067 + Repaglinide (NCT01536366)
- 2015-06-12Also stopped (terminated): Merck Sharp & Dohme LLC, MK0767 (NCT00543010)
- 2015-05-04Results posted on the registry: Merck Sharp & Dohme LLC, Sitagliptin + Placebo (NCT01590771)
- 2015-02-27Results posted on the registry: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Lisinopril + Telmisartan (NCT00283686)
- 2014-11-24Results posted on the registry: Kissei Pharmaceutical Co., Ltd., KAD-1229 (NCT01333592)
- 2014-10-20Results posted on the registry: Eli Lilly and Company, LY2189265 + Insulin glargine (NCT01584232)
- 2014-09-15Results posted on the registry: National Heart, Lung, and Blood Institute (NHLBI), Anti-hyperglycemic Agents + Anti-hypertensive Agents (NCT00000620)
- 2014-08-22Results posted on the registry: Repros Therapeutics Inc., Proellex + CYP1A2 probe (NCT00741468)
- 2014-08-21Results posted on the registry: Virginia Commonwealth University, diazoxide (NCT00683774)
- 2014-07-18Also stopped (terminated): Boehringer Ingelheim, BI 207127 NA + BI 201335 NA (NCT02182401)
- 2014-06-10Also stopped (terminated): University of Chicago, Minoxidil + Hydralazine (NCT00607477)
- 2014-06-03Results posted on the registry: Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc., 5% Minoxidil Topical Foam + Vehicle Topical Foam (NCT01226459)
- 2014-04-25Results posted on the registry: Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc., 5% Minoxidil + 2% Minoxidil (NCT01145625)
- 2014-04-21Results posted on the registry: Takeda, Alogliptin + Rapid-acting insulin secretagogue (NCT01456130)
- 2014-04-10Results posted on the registry: Allergan, bimatoprost Formulation A + bimatoprost Formulation B (NCT01325337)
- 2014-04-09Results posted on the registry: Allergan, bimatoprost Formulation A + bimatoprost Formulation B (NCT01325350)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision